Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Trial of 177Lu-PSMA617 Theranostic Versus Cabazitaxel in Progressive Metastatic Castration Resistant Prostate Cancer (TheraP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03392428
Recruitment Status : Unknown
Verified September 2019 by Australian and New Zealand Urogenital and Prostate Cancer Trials Group.
Recruitment status was:  Active, not recruiting
First Posted : January 8, 2018
Last Update Posted : September 26, 2019
Sponsor:
Collaborators:
Australian Nuclear Science and Technology Organisation (ANSTO)
Endocyte
Prostate Cancer Foundation of Australia (PCFA)
Australasian Radiopharmaceutical Trials network (ARTnet)
Movember Foundation
Information provided by (Responsible Party):
Australian and New Zealand Urogenital and Prostate Cancer Trials Group

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : December 2020
Estimated Study Completion Date : January 2021